[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-cancer-research-uk-biology-to-prevention-award-2026-12":3,"similar-cancer-research-uk-biology-to-prevention-award-2026-12":38},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":11,"deadline_note":12,"duration":13,"trl":12,"relevance":12,"why_relevant":12,"early_career":14,"consortium":15,"first_seen":16,"last_updated":17,"update_note":12,"status":18,"stages":19,"call_frequency":20,"next_call_expected":12,"source_url":7,"created_at":21,"updated_at":22,"last_seen_at":22,"eligible_countries":23,"description":25,"seo_summary":26,"recurring_round":14,"canonical_id":4,"links":27},"cancer-research-uk-biology-to-prevention-award-2026-12","Biology to Prevention Award","Cancer Research UK","https:\u002F\u002Fwww.cancerresearchuk.org\u002Ffor-researchers\u002Fapply-for-and-manage-your-funding\u002Four-funding-schemes\u002Fbiology-to-prevention-award","£100k–£600k",117000,702000,"2026-12-04T00:00:00.000Z",null,"Up to 5 years",false,"Optional — collaborations between cancer prevention researchers and other disciplines strongly encouraged; UK-US (ACS) and UK-Canada (CCS) co-funding partnerships available with joint lead applicants","2026-10-04T00:00:00.000Z","2026-10-18T00:00:00.000Z","open","Single stage, but requires mandatory informal eligibility discussion with CRUK before submission on Flexi-Grant","Biannual","2026-10-04T09:09:17.200Z","2026-10-18T07:50:36.654Z",[24],"GB","Supports translational research on biological mechanisms of cancer prevention; applicant must be postdoctoral-level scientist\u002Fclinician based at UK university, medical school, hospital or research institute, mostly fully funded by host institution. Co-funding partnerships available with US (ACS) and Canadian (CCS) teams.","{\"faq\":[{\"q\":\"How much funding does the CRUK Biology to Prevention Award provide?\",\"a\":\"Awards range from £100k to £600k, covering projects of up to five years.\"},{\"q\":\"Who is eligible for the Biology to Prevention Award?\",\"a\":\"Postdoctoral researchers based at a UK university, medical school, hospital or research institute, with host institution approval.\"},{\"q\":\"Do I need to talk to CRUK before applying?\",\"a\":\"Yes, a mandatory informal discussion with CRUK is required before submitting an application via Flexi-Grant.\"},{\"q\":\"Can international collaborators be included in this grant?\",\"a\":\"Yes, optional co-funding partnerships with American Cancer Society (US) or Canadian Cancer Society (Canada) teams are possible, alongside collaborations with biologists, geneticists, immunologists or drug developers.\"},{\"q\":\"How often does CRUK run this call?\",\"a\":\"The Biology to Prevention Award call runs biannually.\"}],\"key_dates\":[\"Deadline: 4 December 2026\",\"Single-stage application via Flexi-Grant, following mandatory informal discussion with CRUK before submission\",\"Up to 5-year project duration; call runs biannually\"],\"meta_description\":\"CRUK Biology to Prevention Award funds £100k-£600k translational cancer prevention research over up to 5 years for UK-based postdoctoral researchers.\",\"summary\":\"The Biology to Prevention Award from Cancer Research UK funds translational research into the biological mechanisms of cancer prevention, with grants of £100k to £600k over up to five years. It is open to postdoctoral researchers based at a UK university, medical school, hospital or research institute, and encourages collaboration with geneticists, immunologists and drug developers, plus optional co-funding partnerships with American Cancer Society or Canadian Cancer Society teams. Applicants must complete a mandatory informal discussion with CRUK before submitting via Flexi-Grant.\",\"tags\":[\"cancer-prevention\",\"cruk\",\"postdoctoral\",\"translational-research\",\"uk\",\"biannual-call\",\"international-collaboration\"],\"tips\":[\"Book the mandatory informal discussion with CRUK well before the deadline, this is a gating step, not a formality, and can shape the eventual proposal.\",\"If pursuing co-funding with ACS or CCS, coordinate timelines early since partner-country review adds complexity to a single-stage submission.\",\"Frame the biological mechanism clearly in terms of its prevention application; CRUK reviewers for this call expect a translational link, not pure mechanistic biology.\"],\"who_should_apply\":[\"Postdoctoral researchers with experience beyond PhD level\",\"Based at a UK university, medical school, hospital or research institute\",\"Working on biological mechanisms underlying cancer prevention\",\"Interested in cross-disciplinary collaboration with geneticists, immunologists or drug developers\",\"Open to international co-funding partnerships with US or Canadian cancer charities\"]}",{"matchedProgram":12,"resourceSlug":12,"relatedGuides":28,"countryHubs":29,"domainHubs":33,"closingMonth":34,"hasRelated":14,"hasBrowseRelated":37},[],[30],{"slug":31,"demonym":32},"gb","UK researchers",[],{"slug":35,"label":36},"2026-12","December 2026",true,{"grants":39},[40,44,48,53,58],{"id":41,"name":42,"funder":6,"deadline":11,"budget":43},"cancer-research-uk-prevention-and-population-research-project-award-2026-12","Prevention and Population Research Project Award","Up to £500k",{"id":45,"name":46,"funder":6,"deadline":47,"budget":43},"cancer-research-uk-early-detection-and-diagnosis-project-award-2026-12","Early Detection and Diagnosis Project Award","2026-12-03T00:00:00.000Z",{"id":49,"name":50,"funder":6,"deadline":51,"budget":52},"cancer-research-uk-early-detection-and-diagnosis-primer-award-2027-03","Early Detection and Diagnosis Primer Award","2027-03-11T00:00:00.000Z","Up to £100k",{"id":54,"name":55,"funder":56,"deadline":12,"budget":57},"the-mark-foundation-for-cancer-research-aspire-i-award-2026","Aspire Award","The Mark Foundation for Cancer Research","Up to $250k (ASPIRE I, up to $500k for clinical studies) or up to $750k (ASPIRE II)",{"id":59,"name":60,"funder":6,"deadline":12,"budget":61},"cancer-research-uk-childhood-cancer-therapeutic-catalyst-2026","Childhood Cancer Therapeutic Catalyst","Up to £250k"]